These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 33070116)

  • 1. Bronchoscopic intratumoral injections of cisplatin and endostar as concomitants of standard chemotherapy to treat malignant central airway obstruction.
    Jiang W; Yang X; Wang X; Li Y; Yang X; Wang N; Yin B
    Postgrad Med J; 2022 Feb; 98(1156):104-112. PubMed ID: 33070116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restoration of Patency to Central Airways Occluded by Malignant Endobronchial Tumors Using Intratumoral Injection of Cisplatin.
    Mehta HJ; Begnaud A; Penley AM; Wynne J; Malhotra P; Fernandez-Bussy S; Cope J; Shuster JJ; Jantz MA
    Ann Am Thorac Soc; 2015 Sep; 12(9):1345-50. PubMed ID: 26072968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of para-toluenesulfonamide intratumoral injection on non-small cell lung carcinoma with severe central airway obstruction: A multi-center, non-randomized, single-arm, open-label trial.
    Li SY; Li Q; Guan WJ; Huang J; Yang HP; Wu GM; Jin FG; Hu CP; Chen LA; Xu GL; Liu SZ; Wu CG; Han BH; Xiang Y; Zhao JP; Wang J; Zhou X; Li HP; Zhong NS
    Lung Cancer; 2016 Aug; 98():43-50. PubMed ID: 27393505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of endostar combined with cisplatin in treatment of non-small cell lung cancer with malignant pleural effusion: A meta-analysis.
    Hu Y; Zhou Z; Luo M
    Medicine (Baltimore); 2022 Dec; 101(52):e32207. PubMed ID: 36595983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy of endostar combined with chemotherapy in multi-cycle treatment of patients with advanced non-small cell lung cancer].
    Li N; Jin ZL; Liu ZJ; Wang J; Li K
    Zhonghua Zhong Liu Za Zhi; 2011 Dec; 33(12):937-42. PubMed ID: 22340106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic review and meta-analysis of Endostar (rh-endostatin) combined with chemotherapy versus chemotherapy alone for treating advanced non-small cell lung cancer.
    Rong B; Yang S; Li W; Zhang W; Ming Z
    World J Surg Oncol; 2012 Aug; 10():170. PubMed ID: 22917490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Evaluation of Durative Transfusion of Endostar Combined with Chemotherapy in Patients with Advanced Non-Small Cell Lung Cancer.
    Li X; Gu G; Soliman F; Sanders AJ; Wang X; Liu C
    Chemotherapy; 2018; 63(4):214-219. PubMed ID: 30347389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endobronchial intratumoral chemotherapy (EITC) followed by surgery in early non-small cell lung cancer with polypoid growth causing erroneous impression of advanced disease.
    Celikoglu SI; Celikoglu F; Goldberg EP
    Lung Cancer; 2006 Dec; 54(3):339-46. PubMed ID: 17045361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human Recombinant Endostatin Combined with Cisplatin Based Doublets in Treating Patients with Advanced NSCLC and Evaluation by CT Perfusion Imaging.
    Zhang FL; Gao EY; Shu RB; Wang H; Zhang Y; Sun P; Li M; Tang W; Jiang BQ; Chen SQ; Cui FB
    Asian Pac J Cancer Prev; 2015; 16(15):6765-8. PubMed ID: 26434908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HELPER study: A phase II trial of continuous infusion of endostar combined with concurrent etoposide plus cisplatin and radiotherapy for treatment of unresectable stage III non-small-cell lung cancer.
    Zhai Y; Ma H; Hui Z; Zhao L; Li D; Liang J; Wang X; Xu L; Chen B; Tang Y; Wu R; Xu Y; Pang Q; Chen M; Wang L
    Radiother Oncol; 2019 Feb; 131():27-34. PubMed ID: 30773184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective Multicentered Safety and Feasibility Pilot for Endobronchial Intratumoral Chemotherapy.
    Yarmus L; Mallow C; Akulian J; Lin CT; Ettinger D; Hales R; Voong KR; Lee H; Feller-Kopman D; Semaan R; Seward K; Wahidi MM
    Chest; 2019 Sep; 156(3):562-570. PubMed ID: 30776363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized controlled trial of endostar combined with cisplatin/ pemetrexed chemotherapy for elderly patients with advanced malignant pleural effusion of lung adenocarcinoma.
    Jie Wang X; Miao K; Luo Y; Li R; Shou T; Wang P; Li X
    J BUON; 2018; 23(1):92-97. PubMed ID: 29552766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of rh-endostatin (Endostar) combined with pemetrexed/cisplatin followed by rh-endostatin plus pemetrexed maintenance in non-small cell lung cancer: A retrospective comparison with standard chemotherapy.
    Zhou S; Zuo L; He X; Pi J; Jin J; Shi Y
    Thorac Cancer; 2018 Nov; 9(11):1354-1360. PubMed ID: 30152052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy of paclitaxel-carboplatin alone or with endostar for advanced non-small cell lung cancer.
    Han B; Xiu Q; Wang H; Shen J; Gu A; Luo Y; Bai C; Guo S; Liu W; Zhuang Z; Zhang Y; Zhao Y; Jiang L; Zhou J; Jin X
    J Thorac Oncol; 2011 Jun; 6(6):1104-9. PubMed ID: 21532504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome of treated advanced non-small cell lung cancer with and without central airway obstruction.
    Chhajed PN; Baty F; Pless M; Somandin S; Tamm M; Brutsche MH
    Chest; 2006 Dec; 130(6):1803-7. PubMed ID: 17167000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant human endostatin (endostar) decreased recurrent ascites, pleural fluid and ascitic VEGF in a case of advanced mesothelioma.
    Chen X; Liu Y; Yin Y; Jin S; Ping G; Røe OD; Yan K; Shu Y; Guo R
    J Chemother; 2012 Aug; 24(4):231-6. PubMed ID: 23040690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Papillary squamous cell carcinoma successfully treated with bronchoscopic intratumoral injections of cisplatin and Endostar: a case report.
    Wang Y; Li Y; Yin B; Yang X; Wang F; Wang H; Jiang W
    J Int Med Res; 2021 Sep; 49(9):3000605211047077. PubMed ID: 34579594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endostar continuous versus intermittent intravenous infusion combined with chemotherapy for advanced NSCLC: a systematic review and meta-analysis including non-randomized studies.
    Wang B; Xu L; Li Q; Man S; Jin C; Liu L; Zhan S; Ning Y
    BMC Cancer; 2020 Oct; 20(1):1021. PubMed ID: 33087103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Endostar continuous versus intermittent intravenous infusion in combination with first-line chemotherapy in patients with advanced non-small cell lung cancer.
    Cheng Y; Nie L; Liu Y; Jin Z; Wang X; Hu Z
    Thorac Cancer; 2019 Jul; 10(7):1576-1580. PubMed ID: 31161695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of intracavitary administration of Endostar combined with cisplatin in malignant pleural effusion and ascites.
    Zhao WY; Chen DY; Chen JH; Ji ZN
    Cell Biochem Biophys; 2014 Sep; 70(1):623-8. PubMed ID: 24920191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.